About Denice Torres
Denice Torres is a director at Celldex Therapeutics.
Form D filings name Denice Torres as a director at MeridianMade, ByHeart and Seaport Therapeutics.
Denice Torres reports to the SEC as a director of 7 public companies, including Glaukos (GKOS), Seaport Therapeutics (SPTX) and 2seventy bio (TSVT).
Denice Torres first appears on SEC filings in 2020.
Experience
This experience comes from Denice Torres's profile and from SEC filings. For roles taken from filings, the years are when the filings name Denice Torres in the role, so the role may have started earlier or lasted longer.
CI
Celldex Therapeutics, Inc. Current
Member Board of Directors
2025 – Present · Public company (CLDX)
ByHeart, Inc. Current
Member Board of Directors
2024 – Present · New York, NY
Made infant formula for families; the brand has been discontinued.
GC
Glaukos Corp. Current
Director Board Of Directors, member Compensation, Nom/Goc Committee
2021 – Present · Public company (GKOS)
RE
Resilience Current
Director Board Of Directors, Chair of Audit and Risk Committee, member of Compensation Committee
2020 – Present
TC
The Ignited Company Current
Founder and CEO
2017 – Present
GL
GLG Current
Advisor
2017 – Present
MeridianMade, Inc.
Director
2026 · New York, NY
Develops and manufactures infant formula for store brands.
2I
2seventy bio, Inc.
Director Board Of Directors, member of Audit, Compensation and Nom/Gov Committee (Chair)
2021 – 2025 · Public company (TSVT)
KI
Karuna Therapeutics, Inc.
Director Board Of Directors, member of Compensation Committee
2020 – 2024 · Public company (KRTX)
TM
Thirty Madison
Director Board of Directors
2022 – 2024
SI
Surface Oncology, Inc.
Chair Of The Board Of Directors, Chair Compensation Committee
2021 – 2023 · Public company (SURF)
BI
bluebird bio, Inc.
Director Board Of Directors, Nomination/Governance and Comp Committees
2020 – 2021 · Public company (BLUE)
TP
The Mentoring Place
Founder, The Mentoring Place
2015 – 2020
JJ
Johnson & Johnson
Chief Strategy and Business Transformation Officer, Medical Device
2004 – 2017
EC
Eli Lilly and Company
Executive Director, Marketing, General Management
1990 – 2004
SR
Smith Haughey Rice & Roegge
Attorney At Law
1985 – 1986
Key Colleagues at Startups
The people Denice Torres works with at each company, as listed on that company's latest Form D.
MeridianMade, Inc. · Form D, Jul 24, 2026
GO
Guy Oranim
Director
AB
Arie Belldegrun
Director
Niall Mullane
Chief Quality Officer
GV
Georg Krause-Vilmar
Executive officer
Ron Belldegrun
CEO & Co-Founder, director
AS
Amy Schulman
Director
HZ
Hemi Zucker
Director
Mia Funt
President & Co-Founder, director
RW
Raphael Wallander
Director
Devon Kuehn
Chief Medical & Scientific Officer
JK
Joshua Kazam
Director
Neil Betteridge
Chief Operating Officer
ByHeart, Inc. · Form D/A, May 7, 2026
RW
Raphael Wallander
Director
Niall Mullane
Executive officer
HZ
Hemi Zucker
Director
AS
Amy Schulman
Chair of the Board
EA
Elizabeth Abrams
Director
TB
Tommy Burke
Director
GV
Georg Krause-Vilmar
Chief Legal Officer
AB
Arie Belldegrun
Director
Mia Funt
Co-Founder and President, director
Devon Kuehn
Executive officer
AL
Anton Linderum
Director
Ron Belldegrun
CEO and Co-Founder, director
JB
Joshua Bradley
Director
JK
Joshua Kazam
Director
GO
Guy Oranim
Director
Seaport Therapeutics, Inc. · Form D, Oct 31, 2024
JH
James Healy
Director
MC
Michael Chen
Executive officer
LG
Lana Gladstein
General Counsel
DZ
Daphne Zohar
Executive officer and director
AL
Antony Loebel
Executive officer
DW
David Wheadon
Director
EG
Eric Green
Executive officer
RN
Robert Nelsen
Director
SP
Steven Paul
Director
BC
Bharatt Chowrira
Director
EE
Eric Elenko
Director
JP
Jason Pitts
Director